PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Clinical Pharmacology and Toxicology, Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.\', \'Division of General Internal Medicine, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'Personalized Health and Related Technologies, Swiss Federal Institute of Technology in Zurich, Zurich, Switzerland.\', \'Faculty of Medicine, University of Geneva, Geneva, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/cpt.2412
?:doi
?:hasPublicationType
?:journal
  • Clinical pharmacology and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34473836
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all